Vimarsana
Biggest News Aggregation in the World

Cell Therapy Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Therapy Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Therapy Systems Today - Breaking & Trending Today

Validated software solution to automate cell therapy - Vimarsana News

Validated software solution to automate cell therapy

Thermo Fisher Scientific announces the launch of the Gibco Cell Therapy Systems (CTS) Cellmation Software

Innovative software transforms cell therapy manufacturing processes - Vimarsana News

Innovative software transforms cell therapy manufacturing processes

Thermo Fisher Scientific introduces the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software. Click to read more...

Thermo Fisher Scientific helps accelerate cell therapy - Vimarsana News

Thermo Fisher Scientific helps accelerate cell therapy

Thermo Fisher Scientific helps accelerate cell therapy manufacturing with a next-generation platform

Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies - Vimarsana News

Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies

Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, today announced an update to our strategic collaboration to further the development of manufacturing processes for new cancer treatments.

Thermo Fisher and Arsenal Biosciences to support clinical manufacturing of autologous T-cell therapies - Vimarsana News

Thermo Fisher and Arsenal Biosciences to support clinical manufacturing of autologous T-cell therapies

As ArsenalBio pioneers a new approach to treat solid tumours using engineered T cell therapies